Rubicon Research

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE506V01022
  • NSEID: RUBICON
  • BSEID: 544578
INR
626.30
2.3 (0.37%)
BSENSE

Dec 05

BSE+NSE Vol: 7.82 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Sep'24
Net Sales
412.02
352.49
296.01
Other Operating Income
0.00
0.00
0.00
Total Operating income
412.02
352.49
296.01
Raw Material Cost
142.18
134.15
92.00
Purchase of Finished goods
21.21
3.37
18.47
(Increase) / Decrease In Stocks
-36.84
-34.59
-31.33
Employee Cost
63.36
58.21
51.27
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
127.80
112.25
103.93
Total Expenditure (Excl Depreciation)
317.72
273.39
234.34
Operating Profit (PBDIT) excl Other Income
94.30
79.10
61.67
Other Income
0.70
0.63
2.66
Operating Profit (PBDIT)
95.00
79.73
64.33
Interest
11.42
10.62
7.02
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
83.58
69.11
57.31
Depreciation
11.87
9.57
8.15
Profit Before Tax
71.71
59.56
49.15
Tax
17.85
16.26
14.68
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
53.85
43.30
34.48
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
53.85
43.30
34.48
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
53.85
43.30
34.48
Equity Capital
15.44
15.41
15.41
Face Value
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
3.49
2.81
2.24
Diluted Earnings per share
3.47
2.79
2.23
Operating Profit Margin (Excl OI)
22.89%
22.44%
20.83%
Gross Profit Margin
20.29%
19.61%
19.36%
PAT Margin
13.07%
12.28%
11.65%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 21.02% vs 9.07% in Jun 2025

stock-summary

Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is 30.33% vs -18.05% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 25.27% vs -7.69% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is 4.07% vs 38.71% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Rubicon Research With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
412.02
0
412.02
Other Operating Income
0.00
0.00
0.00
Total Operating income
412.02
0
412.02
Raw Material Cost
142.18
0
142.18
Purchase of Finished goods
21.21
0
21.21
(Increase) / Decrease In Stocks
-36.84
0
-36.84
Employee Cost
63.36
0
63.36
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.01
0
0.01
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
127.80
0.00
127.80
Total Expenditure (Excl Depreciation)
317.72
0
317.72
Operating Profit (PBDIT) excl Other Income
94.30
0.00
94.30
Other Income
0.70
0
0.70
Operating Profit (PBDIT)
95.00
0
95.00
Interest
11.42
0
11.42
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
83.58
0
83.58
Depreciation
11.87
0
11.87
Profit Before Tax
71.71
0
71.71
Tax
17.85
0
17.85
Provisions and contingencies
0.00
0
0.00
Profit After Tax
53.85
0
53.85
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
53.85
0
53.85
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
53.85
0
53.85
Equity Capital
15.44
0
15.44
Face Value
1.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
3.49
0
3.49
Diluted Earnings per share
3.47
0
3.47
Operating Profit Margin (Excl OI)
22.89%
0%
0.00
22.89%
Gross Profit Margin
20.29%
0%
0.00
20.29%
PAT Margin
13.07%
0%
0.00
13.07%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 336.47 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 21.02% vs 9.07% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 32.00%

Quarterly - Standalone Net Profit
Standalone Net Profit 45.81 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 30.33% vs -18.05% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 6.81%

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 79.11 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 25.27% vs -7.69% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 15.64%

Quarterly - Interest
Interest 9.21 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 4.07% vs 38.71% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 44.36%

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.51%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024